| Primary |
| Drug Use For Unknown Indication |
29.3% |
| Diarrhoea |
23.6% |
| Product Used For Unknown Indication |
20.5% |
| Drug Exposure During Pregnancy |
5.8% |
| Hypertension |
2.8% |
| Gastroenteritis |
1.9% |
| Hiv Infection |
1.8% |
| Epilepsy |
1.7% |
| Influenza |
1.4% |
| Nausea |
1.4% |
| Pain |
1.2% |
| Prophylaxis |
1.1% |
| Suicide Attempt |
1.1% |
| Gout |
1.0% |
| Ill-defined Disorder |
1.0% |
| Pyrexia |
1.0% |
| Suicidal Ideation |
1.0% |
| Infection |
0.9% |
| Plasma Cell Leukaemia |
0.9% |
| Abdominal Pain |
0.8% |
|
| Suicide Attempt |
13.0% |
| Overdose |
8.7% |
| Vomiting |
7.5% |
| Intestinal Obstruction |
6.8% |
| Intentional Drug Misuse |
6.2% |
| Urticaria |
6.2% |
| Weight Decreased |
6.2% |
| Urinary Retention |
5.6% |
| Syncope |
4.3% |
| Drug Dependence |
3.7% |
| Intentional Overdose |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Small Intestinal Obstruction |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Drug Abuse |
3.1% |
| Loss Of Consciousness |
3.1% |
| Somnolence |
3.1% |
| Constipation |
2.5% |
| Diarrhoea |
2.5% |
| Drug Exposure During Pregnancy |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
20.1% |
| Drug Use For Unknown Indication |
18.5% |
| Diarrhoea |
16.3% |
| Crohn's Disease |
15.1% |
| Nausea |
4.2% |
| Pain |
4.1% |
| Hypertension |
2.7% |
| Drug Exposure During Pregnancy |
2.6% |
| Diabetes Mellitus |
2.1% |
| Hiv Infection |
1.9% |
| Accidental Exposure |
1.7% |
| Epilepsy |
1.6% |
| Prophylaxis |
1.4% |
| Depression |
1.3% |
| Influenza |
1.3% |
| Vomiting |
1.1% |
| Ill-defined Disorder |
1.0% |
| Pyrexia |
1.0% |
| Unevaluable Event |
1.0% |
| Insomnia |
0.9% |
|
| Toxic Epidermal Necrolysis |
13.4% |
| Renal Failure Acute |
8.1% |
| Weight Decreased |
7.6% |
| Crohn's Disease |
7.0% |
| Suicide Attempt |
6.4% |
| Vomiting |
6.4% |
| Diarrhoea |
5.8% |
| Overdose |
5.2% |
| Intestinal Obstruction |
4.7% |
| Wrong Technique In Drug Usage Process |
4.1% |
| Death |
3.5% |
| Pyrexia |
3.5% |
| Stevens-johnson Syndrome |
3.5% |
| Urinary Retention |
3.5% |
| Colitis Ischaemic |
2.9% |
| Gamma-glutamyltransferase Increased |
2.9% |
| Intentional Drug Misuse |
2.9% |
| Prothrombin Time Prolonged |
2.9% |
| Rectal Haemorrhage |
2.9% |
| Somnolence |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.8% |
| Drug Use For Unknown Indication |
16.7% |
| Crohn's Disease |
9.7% |
| Diarrhoea |
9.1% |
| Hypertension |
5.2% |
| Pain |
4.8% |
| Prophylaxis |
4.6% |
| Nausea |
4.1% |
| Breast Cancer |
3.5% |
| Non-small Cell Lung Cancer |
2.8% |
| Multiple Myeloma |
2.2% |
| Depression |
2.2% |
| Hiv Infection |
2.1% |
| Diabetes Mellitus |
2.1% |
| Anxiety |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Insomnia |
1.8% |
| Colorectal Cancer Metastatic |
1.5% |
| Colorectal Cancer |
1.5% |
| Colitis Ulcerative |
1.5% |
|
| Vomiting |
19.2% |
| Weight Decreased |
10.7% |
| Diarrhoea |
9.5% |
| Pyrexia |
5.5% |
| Nausea |
4.9% |
| Renal Failure Acute |
4.6% |
| Urinary Tract Infection |
4.2% |
| Renal Failure |
3.9% |
| Rash |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Sepsis |
3.6% |
| Pulmonary Embolism |
3.5% |
| Dehydration |
3.2% |
| Death |
3.2% |
| Thrombocytopenia |
3.0% |
| Pneumonia |
2.9% |
| Intestinal Obstruction |
2.7% |
| Neutropenia |
2.7% |
| Respiratory Failure |
2.4% |
| Weight Increased |
2.4% |
|
| Interacting |
|
|
